Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Neurofibrosarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1 Carcinoma, Basal Cell 1

Interventions

Nivolumab 3 Specimen Handling 2 Radiotherapy 2 Ipilimumab 2 CTLA-4 Antigen 2 tocilizumab 1 talimogene laherparepvec 1 sonidegib 1 prednylidene 1 poly ICLC 1 pembrolizumab 1 flt3 ligand protein 1 deltacortene 1 cemiplimab 1 Tomography, Optical Coherence 1 Tacrolimus 1 Radiation 1 Prednisone 1 Papillomavirus Vaccines 1 Mohs Surgery 1 Microscopy, Confocal 1 Magnetic Resonance Spectroscopy 1 MAPRE1 protein, human 1 Blood Specimen Collection 1 Biopsy 1 BO-112 1 Aminolevulinic Acid 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Carcinoma, Basal Cell × BO-112 × Clear all

NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡